You are here

P&T News

December 18

December 14

Monitoring the Future survey shows marijuana use remains common
Cream targets Staphylococcus aureus and Streptococcus pyogenes
Biotech companies, often younger and smaller, fare better
The company, which already sells Inflectra, got Ixifi in Hospira purchase
New website may aid appropriate treatment choices

December 12

Manufacturer used FDA’s 505(b)(2) abbreviated approval pathway
This is the first drug for patients with eosinophilic granulomatosis with polyangiitis
Industry will provide funding for programs in partnership with Addiction Policy Forum
Platform offers advanced technology to treat symptoms of Parkinson’s disease

December 11

Pfizer launches generic to counteract Teva’s version
Four in 10 remain in complete remission, updated data show
Patients with high PD-L1 level show benefit in first-line treatment

December 7

Tecentriq was combined with Avastin and chemotherapy as initial treatment
First new drug approach to depression in two decades, company says
Six million affected today, 15 millions four decades from now

December 6

Once-weekly GLP-1 receptor agonist to be available in early 2018

December 5

Setback follows announcement of adverse patient outcomes with dengue vaccine
New technology would allow oral dosing of drugs typically administered by injection

Pages